New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 11, 2014
05:35 EDTNXTMNxStage Medical downgraded to Underperform from Market Perform at Wells Fargo
Wells Fargo downgraded NxStage Medical to Underperform on concern the company's plans to 10-15 dialysis centers in the U.S. by the end of 2014 will not significantly increase the number of home hemodialysis patients and may put in-center revenue at risk. Wells lowered its price target range for shares to $10-$12 from $11-$14.
News For NXTM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 26, 2015
07:33 EDTNXTMNxStage Medical sees Q1 revenue $77.5M-$78.5, consensus $78.49M
Subscribe for More Information
07:32 EDTNXTMNxStage Medical sees FY15 revenue $324.0M-$328.0M, consensus $323.93M
Sees FY15 net loss $20.0M-$24.0M. Targets FY15 cash usage reduction of 50% vs. 2014.
07:30 EDTNXTMNxStage Medical reports Q4 EPS (8c), consensus (10c)
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use